Hepatocellular Carcinoma New Reference: Lenvatinib and Pembrolizumab for HCC Ulas D. Bayraktar, MD 2025-03-02
Hepatocellular Carcinoma New Indication: Adjuvant Atezolizumab – Bevacizumab in HCC Ulas D. Bayraktar, MD 2023-06-24
Hepatocellular Carcinoma New Protocol: Tremelimumab and Durvalumab for HCC Ulas D. Bayraktar, MD 2023-01-10
Hepatocellular Carcinoma New Reference: Cabozantinib and Atezolizumab in HCC Ulas D. Bayraktar, MD 2022-11-26
